Publications by authors named "L A Danzig"
This cross-sectional study uses molecular and serologic methods to investigate the 2021 surge in COVID-19 cases among vaccine recipients in Mongolia.
View Article and Find Full Text PDFImportance: Early treatment of mild SARS-CoV-2 infection might lower the risk of clinical deterioration in COVID-19.
Objective: To determine whether oral camostat mesylate would reduce upper respiratory SARS-CoV-2 viral load in newly diagnosed outpatients with mild COVID-19, and would lead to improvement in COVID-19 symptoms.
Design: From June, 2020 to April, 2021, we conducted a randomized, double-blind, placebo-controlled phase 2 trial.
Article Synopsis
- * An oral live attenuated vaccine named CVD 103-HgR (VAXCHORA™) was approved by the U.S. FDA in 2016, marking the first cholera vaccine available for U.S. travelers in decades, and it offers effective protection after just one dose.
- * Ongoing research aims to assess the vaccine's safety and effectiveness in children, improve storage requirements for global distribution, and enhance its formulation for better administration in resource-limited settings.
Background: Hepatitis E virus (HEV) is an emerging threat to the safety of blood transfusion. The aim of this study was to determine HEV immunoglobulin (Ig)G and RNA prevalence in Catalan blood donors.
Study Design And Methods: Nearly 10,000 samples were collected from anonymized, unpaid donors at the Banc de Sang i Teixits (Barcelona, Spain) from June to December 2013.
Background: In 2001, a mass immunization campaign was implemented in the province of Quebec, Canada, using a new serogroup C meningococcal conjugate vaccine (C-MCV).
Objective: To describe methodological difficulties in the investigation of the mortality risk associated with administration of C-MCV using large administrative databases, and to present possible solutions.
Materials And Methods: The study population included approximately 1.